Schedule 13G ownership disclosure

MOLECULIN BIOTECH INC

Security class unavailable · CUSIP: 60855D101

Event date: 2019-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-19-002792
Form type
SC 13G
Filer
ARMISTICE CAPITAL, LLC
CIK
CIK 1601086
Filed
Apr 08, 2019
Reporting period
Mar 27, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub